NCT01017276View on ClinicalTrials.gov

A Phase 3 Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Peritoneal Dialysis

PHASE3CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions
Chronic Kidney DiseaseRenal DialysisRenal Insufficiency
Interventions
DRUG

ASP1585

oral

Trial Locations (3)

Unknown

Chugoku

Chūbu

Kantou

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT01017276 - A Phase 3 Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Peritoneal Dialysis | Biotech Hunter | Biotech Hunter